DEBORAH CHONG, MD
Ophthalmology Physician · DALLAS, TX
Individual Active NPI 1841318284
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 884 | 26,429 | $8,370,203 | $3,004,978 | $2,367,242 |
| 2023 | 904 | 30,526 | $8,312,065 | $3,045,119 | $2,389,206 |
| 2022 | 901 | 13,094 | $7,868,507 | $2,887,331 | $2,270,276 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 15,781 | $35 | $27 |
| 92134 | Imaging of retina | 2,139 | $41 | $32 |
| 92014 | Established patient complete exam of visual system | 1,769 | $129 | $93 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,329 | $332 | $264 |
| J0178 | Injection, aflibercept, 1 mg | 1,252 | $825 | $657 |
| 67028 | Injection of drug into eye | 1,101 | $123 | $93 |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | 720 | $48 | $38 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 364 | $195 | $156 |
| 92004 | New patient complete exam of visual system | 238 | $153 | $113 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 135 | $164 | $132 |
| J2778 | Injection, ranibizumab, 0.1 mg | 128 | $158 | $126 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 73 | $25 | $19 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | M9215 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1083175558
- NPI 1386010122
- NPI 1679716948
- NPI 1538801063
- NPI 1114567476
- NPI 1275594376
- NPI 1124551163
- NPI 1093202004
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.